Cas:128694-63-3 2-Methyl-5-trifluoroMethyl-2H-pyrazole-3-carboxylic acid manufacturer & supplier

We serve Chemical Name:2-Methyl-5-trifluoroMethyl-2H-pyrazole-3-carboxylic acid CAS:128694-63-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Methyl-5-trifluoroMethyl-2H-pyrazole-3-carboxylic acid

Chemical Name:2-Methyl-5-trifluoroMethyl-2H-pyrazole-3-carboxylic acid
CAS.NO:128694-63-3
Synonyms:2-methyl-5-(trifluoromethyl)pyrazole-3-carboxylic acid;1H-Pyrazole-5-carboxylic acid, 1-methyl-3-(trifluoromethyl)-;1-Methyl-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid;1-Methyl-3-trifluoromethyl-1H-pyrazole-5-carboxylic acid
Molecular Formula:C6H5F3N2O2
Molecular Weight:194.111
HS Code:2933199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:288.8±40.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.498
PSA:55.12000
Exact Mass:194.030319
LogP:1.10

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-methyl-5-(trifluoromethyl)pyrazole-3-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Methyl-3-trifluoromethyl-1H-pyrazole-5-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-methyl-5-(trifluoromethyl)pyrazole-3-carboxylic acid Use and application,1-Methyl-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid technical grade,usp/ep/jp grade.


Related News: Brian McNamara, currently head of GSK’s consumer healthcare division, will continue to serve as the franchise’s CEO after it breaks away from GSK in 2022, the British pharma said Thursday. tert-butyl N-[4-[4-(aminomethyl)phenyl]phenyl]carbamate manufacturers AZ’s chief financial officer and incoming Alexion head Marc Dunoyer acknowledged that the reimbursement infrastructure for rare disease drugs in China isn’t as advanced as it is in many developed economies. The rare disease market in China is still small, but there’s a growing recognition of its importance from authorities, he added. (2S,4S)-2-amino-4-(4-methylbenzyl)pentanedioic acid suppliers The CDC’s Advisory Committee on Immunization Practices (ACIP) decision on Thursday came after an hours-long discussion over a handful of Guillain-Barré syndrome (GBS) cases reported after J&J’s jab. The independent group of experts were also tasked with reviewing the need for booster shots, specifically for people with compromised immune systems. tert-butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate vendor & factory.